glp 1 trial Another milestone in the evolution of GLP-1-based diabetes therapies Virta Health announces first-of-its-kind peer-reviewed

We have examined seven ways these treatments improve health outcomes across multiple body systems

By stimulating both GLP-1 and GIP receptors, it reduces appetite, prolongs feelings of fullness, enhances insulin sensitivity, and could potentially increase your body's calorie-burning rates

The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon

Difficulty finding words mid-sentence, trouble concentrating during meetings, feeling mentally foggy

Access to diabetes technology and newer medications like GLP-1s remains a challenge due high out-of-pocket costs as well as shortages of GLP-1s

"Obesity must be viewed like other chronic diseases, where sometimes more than one therapy is necessary over time and for different reasons," added Kurian, who was not involved in the study